Exchange: NASDAQ·Updated 07:46 PM EDT
CADL logo

CADL Candel Therapeutics Inc

$12.78
$0.19
(1.47%)
Today
Closed $12.78
$0.03
(0.23%)
After Hours
Reported EarningsAug 13
Mkt Cap$977.91M
Vol535,822.00

About CADL

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
30

Bearish Sentiment

How do you feel about CADL?

Advertisement|Remove ads.